ICNMD 2026 Annual Congress

The International Congress on Neuromuscular Diseases (ICNMD) is a global scientific congress focused on neuromuscular disorders, bringing together healthcare professionals and researchers to share advances in clinical and translational science. The Specialty Group on Neuromuscular Diseases (NMD) of the World Federation of Neurology (WFN) organizes the event. The 2026 steering committee includes Congress President Antonio Toscano, ICNMD Chair P. James B. Dyck, and WFN President Wolfgang Grisold.

Don’t miss: On-demand symposium on advancing TK2d management

Register now to access Medthority’s EBAC-accredited, on-demand symposium: “Advancing TK2d management: From natural history to clinical evidence and real-world opportunities.”

In this symposium – taking place at ICNMD 2026 – Caterina Garone, Yolanda Cámara, and Cristina Domínguez González will explore disease mechanisms in thymidine kinase 2 deficiency (TK2d), emerging clinical evidence, and real-world insights to support efficient diagnosis, patient monitoring, and effective treatment.

If you’re unable to attend ICNMD this year, register below and we’ll let you know as soon as this symposium becomes available to watch on demand.

SIGN UP NOW

Agenda

Meet the experts

Caterina Garone, MD, PhD

Caterina Garone is Associate Professor of Medical Genetics at Alma Mater Studiorum, University of Bologna, Italy, and a pediatric neurologist at UOC Neuropsichiatria dell'Età Pediatrica, S. Orsola Hospital.

Garone specializes in clinical and translational research on metabolic disorders, mitochondrial diseases, neuromuscular diseases, and human genetics, with a particular focus as a neurogeneticist.

Disclosures: Serves on an advisory board of UCB Pharma. Received funding from UCB Pharma for research projects relating to TK2d.

Yolanda Cámara, PhD

Yolanda Cámara is a Principal Investigator at Vall d’Hebron Institute of Research, Barcelona, Spain.

Cámara specializes in neuromuscular and mitochondrial pathology, with her research focused on the molecular mechanisms underlying mitochondrial diseases and disorders of oxidative metabolism, spanning both basic and translational research.

Disclosures: No disclosures reported.

Cristina Domínguez González, MD, PhD

Cristina Domínguez González leads multidisciplinary clinical and research groups at the Hospital 12 de Octubre in Madrid, Spain.

Domínguez González’s area of expertise lies in genetic myopathies, with a particular focus on those originating from metabolic and mitochondrial factors.

Disclosures: Consulting fees from Amicus Therapeutics, Exeltis, Italfarmaco, Modis Therapeutics, Pharmanext, Roche, Sarepta, Sanofi–Genzyme, UCB Pharma, and Zogenix. Research funding from Pretzel Therapeutics and UCB Pharma. Honoraria from Amicus Therapeutics, Roche, Sanofi–Genzyme, and UCB Pharma.

Developed by EPG Health. This content has been developed independently of the sponsor, UCB, which had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education, and associated relevant content. This content is intended for healthcare professionals only.

When is ICNMD 2026?

ICNMD 2026 takes place July 7–11, 2026, in Florence, Italy.

How do I register for ICNMD 2026?

For registration details and more information on the upcoming ICNMD 2026 program, visit the event website.